PROGNOSTIC SIGNIFICANCE RBC TRANSFUSIONS' VOLUME INFUSED DURING THE FIRST INDUCTION CHEMOTHERAPY TO PATIENTS WITH DE NOVO ACUTE MYELOID LEUKEMIA (AML)

被引：0
作者：
Davaasambuu, B. [1 ]
Gritsaev, S. [1 ]
机构：
[1] Russian Inst Hematol & Transfusiol, St Petersburg, Russia
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1304
引用
收藏
页码：533 / 533
页数：1
相关论文
共 50 条
  • [21] A Phase II Trial of Sirolimus with Standard Induction Chemotherapy in Patients with De Novo Acute Myeloid Leukemia
    Keiffer, Gina
    Palmisiano, Neil
    Jeschke, Grace
    Leiby, Benjamin
    Alpdogan, Onder
    Carabasi, Matthew
    Filicko-O'Hara, Joanne
    Gaballa, Sameh
    Grosso, Dolores
    Klumpp, Thomas
    Martinez, Ubaldo
    Wagner, John
    Carroll, Martin
    Porcu, Pierluigi
    Flomenberg, Neal
    Perl, Alexander
    Kasner, Margaret
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S203 - S204
  • [22] Dyshematopoiesis in de novo acute myeloid leukemia:: Cell biological features and prognostic significance
    Meckenstock, G
    Aul, C
    Hildebrandt, B
    Heyll, A
    Germing, U
    Wehmeier, A
    Giagounidis, A
    Suedhoff, T
    Burk, M
    Soehngen, D
    Schneider, W
    LEUKEMIA & LYMPHOMA, 1998, 29 (5-6) : 523 - 531
  • [23] Intrinsic susceptibility to apoptosis predicts remission induction in de novo acute myeloid leukemia (AML).
    Kasamon, YL
    Jones, RJ
    Vala, MS
    Zahurak, ML
    Garrett, ES
    Smith, BD
    BLOOD, 2003, 102 (11) : 236B - 236B
  • [24] A Phase II Trial of Sirolimus with Standard Induction Chemotherapy in Patients with De Novo Acute Myeloid Leukemia
    Palmisiano, Neil
    Jeschke, Grace
    Leiby, Benjamin E.
    Alpdogan, Onder
    Carabasi, Matthew
    Filicko-O'Hara, Joanne
    Gaballa, Sameh
    Grosso, Dolores
    Klumpp, Thomas R.
    Outschoorn, Ubaldo Martinez
    Wagner, John L.
    Carroll, Martin
    Porcu, Pierluigi
    Flomenberg, Neal
    Perl, Alexander E.
    Kasner, Margaret
    BLOOD, 2017, 130
  • [25] CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia
    Lin, T-C
    Hou, H-A
    Chou, W-C
    Ou, D-L
    Yu, S-L
    Tien, H-F
    Lin, L-I
    LEUKEMIA, 2011, 25 (01) : 32 - 40
  • [26] A seasonal pattern of presentation in younger patients with de novo acute myeloid leukemia (AML).
    Drapkin, Benjamin Jacob
    Sadrzadeh, Hossein
    Brunner, Andrew Mark
    Werner, Lillian
    Babirak, Loren
    Attar, Eyal C.
    Ballen, Karen K.
    McAfee, Steven L.
    Amrein, Philip C.
    Chen, Yi-Bin Albert
    Stone, Richard M.
    Fathi, Amir Tahmasb
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy
    Boissel, N
    Cayuela, JM
    Preudhomme, C
    Thomas, X
    Grardel, N
    Fund, X
    Tigaud, I
    Raffoux, E
    Rousselot, P
    Sigaux, F
    Degos, L
    Castaigne, S
    Fenaux, P
    Dombret, H
    LEUKEMIA, 2002, 16 (09) : 1699 - 1704
  • [28] Residual Leukemic Cells Population and Immunophenotyping Shifts after the First Induction Course in DE NOVO Acute Myeloid Leukemia (AML)
    Lobanova, T.
    Kapranov, N.
    Davydova, Y.
    Galtseva, I.
    Troitskaya, V.
    Parovichnikova, E.
    ANNALS OF HEMATOLOGY, 2017, 96 : S63 - S64
  • [29] Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy
    N Boissel
    JM Cayuela
    C Preudhomme
    X Thomas
    N Grardel
    X Fund
    I Tigaud
    E Raffoux
    P Rousselot
    F Sigaux
    L Degos
    S Castaigne
    P Fenaux
    H Dombret
    Leukemia, 2002, 16 : 1699 - 1704
  • [30] CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia
    T-C Lin
    H-A Hou
    W-C Chou
    D-L Ou
    S-L Yu
    H-F Tien
    L-I Lin
    Leukemia, 2011, 25 : 32 - 40
12345